A new research project funded by Prostate Cancer UK has the potential to revolutionise the way men with the deadliest prostate cancers are diagnosed and treated — giving them greater certainty of longer and healthier lives.

This new £1.5 million project, harnessing artificial intelligence and cutting-edge genetic analysis, could arm doctors with a tool that predicts whether a man’s prostate cancer will be aggressive at the point of diagnosis, enabling them to give him the best targeted treatment quickly before it spreads and becomes too late to cure.